CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.

Jing Yang,Pengfei Li,Yingshi Piao,Xindi Liu,Liqiang Wei,Wei Sang,Luo Zhang,Liang Wang

Frontiers in immunology（2022）

引用 2|浏览10

暂无评分

摘要

CD56 negative NKTCL differs from CD56 positive NKTCL in both the tumor microenvironment and survival outcomes, and asparaginase-based treatment may overcome the poor prognosis brought by CD56 negativity.

查看译文

关键词

asparaginase,bioinformatics analysis,extranodal natural killer/T cell lymphoma,prognosis,tumor microenvironment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要